False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer
Search for other papers by Anya Litvak in
Current site
Google Scholar
PubMed
Search for other papers by Andrea Cercek in
Current site
Google Scholar
PubMed
Search for other papers by Neil Segal in
Current site
Google Scholar
PubMed
Search for other papers by Diane Reidy-Lagunes in
Current site
Google Scholar
PubMed
Search for other papers by Zsofia K. Stadler in
Current site
Google Scholar
PubMed
Search for other papers by Rona D. Yaeger in
Current site
Google Scholar
PubMed
Search for other papers by Nancy E. Kemeny in
Current site
Google Scholar
PubMed
Search for other papers by Martin R. Weiser in
Current site
Google Scholar
PubMed
Search for other papers by Melissa S. Pessin in
Current site
Google Scholar
PubMed
Search for other papers by Leonard Saltz in
Current site
Google Scholar
PubMed
Routine monitoring of carcinoembryonic antigen (CEA) levels is standard in patients with resected colorectal cancer (CRC). The incidence of false-positives and the upper limits of false-positive elevations have not been previously well characterized. A search of medical records at Memorial Sloan-Kettering Cancer Center identified 728 patients who underwent an R0 resection of locoregional CRC between January 2003 and December 2012 and who had an increase in CEA level above the normal range after a normal perioperative CEA level. Of these, 358 had a false-positive elevation of CEA level, 335 had a true-positive elevation indicative of recurrent CRC, and 35 had a true-positive elevation indicative of the development of a new, non-CRC malignancy. Of those with false elevations, 111 had a single isolated CEA level elevation (median highest CEA level of 5.5 ng/mL) with no further abnormal measurements, whereas 247 had elevations on 2 or more readings, with a median highest level of 6.7 ng/mL. Of these 247 patients with confirmed false-positive CEA level elevations, only 5 (2%) had measurements greater than 15 ng/mL, and no confirmed elevation greater than 35 ng/mL was a false-positive. False-positive CEA test results in the range of 5 to 15 ng/mL are common. Confirmation of CEA elevation in this range before initiating imaging studies may be appropriate. False-positive results greater than 15 ng/mL are rare, and all confirmed CEA levels greater than 35 ng/mL were associated with cancer recurrence.
Supplementary Materials
- Supplemental Material (PDF 174 KB)
© 2019-2024 National Comprehensive Cancer Network